JP2008503221A - Ｐｒｒｓｖサブユニットワクチン - Google Patents

Ｐｒｒｓｖサブユニットワクチン Download PDF

Info

Publication number
JP2008503221A
JP2008503221A JP2007516840A JP2007516840A JP2008503221A JP 2008503221 A JP2008503221 A JP 2008503221A JP 2007516840 A JP2007516840 A JP 2007516840A JP 2007516840 A JP2007516840 A JP 2007516840A JP 2008503221 A JP2008503221 A JP 2008503221A
Authority
JP
Japan
Prior art keywords
prrsv
orf1
sequence
dna
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007516840A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008503221A5 (enExample
Inventor
エリック エム． ヴォーゲン
リチャード スタマー
Original Assignee
ベーリンガー インゲルヘイム ヴェトメディカ アイエヌシー．
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ベーリンガー インゲルヘイム ヴェトメディカ アイエヌシー． filed Critical ベーリンガー インゲルヘイム ヴェトメディカ アイエヌシー．
Publication of JP2008503221A publication Critical patent/JP2008503221A/ja
Publication of JP2008503221A5 publication Critical patent/JP2008503221A5/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10071—Demonstrated in vivo effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2007516840A 2004-06-17 2005-06-17 Ｐｒｒｓｖサブユニットワクチン Withdrawn JP2008503221A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58135004P 2004-06-17 2004-06-17
US11/154,617 US7722878B2 (en) 2004-06-17 2005-06-16 PRRSV subunit vaccines
PCT/US2005/021973 WO2006002193A2 (en) 2004-06-17 2005-06-17 Prrsv subunit vaccines

Publications (2)

Publication Number Publication Date
JP2008503221A true JP2008503221A (ja) 2008-02-07
JP2008503221A5 JP2008503221A5 (enExample) 2008-08-07

Family

ID=35431312

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007516840A Withdrawn JP2008503221A (ja) 2004-06-17 2005-06-17 Ｐｒｒｓｖサブユニットワクチン

Country Status (14)

Country Link
US (1) US7722878B2 (enExample)
EP (1) EP1755664B1 (enExample)
JP (1) JP2008503221A (enExample)
KR (1) KR20070028431A (enExample)
AR (1) AR049825A1 (enExample)
AU (1) AU2005258092A1 (enExample)
BR (1) BRPI0510930A (enExample)
CA (1) CA2570778A1 (enExample)
DK (1) DK1755664T3 (enExample)
ES (1) ES2546933T3 (enExample)
MX (1) MXPA06014821A (enExample)
RU (1) RU2007101531A (enExample)
TW (1) TW200603825A (enExample)
WO (1) WO2006002193A2 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0839912A1 (en) * 1996-10-30 1998-05-06 Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
CA2366072C (en) 1999-03-08 2007-07-10 Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. Prrsv vaccines
ES2348159T3 (es) 1999-04-22 2010-11-30 United States Department Of Agriculture Vacuna contra el sindrome respiratorio y reproductivo porcino basada en el aislado ja-142.
TW200604526A (en) 2004-06-18 2006-02-01 Unviersity Of Minnesota Identifying virally infected and vaccinated organisms
US7632636B2 (en) 2004-09-21 2009-12-15 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome isolates and methods of use
PT2369001T (pt) 2005-06-24 2016-10-25 Univ Minnesota Vírus srrp, clones infecciosos, os seus mutantes e processos de utilização
US8436337B2 (en) * 2009-05-12 2013-05-07 The State of Oregon Acting By and Through The State Board of Higher Education on Behalf of Oregon State Unitiversity Amorphous multi-component metallic thin films for electronic devices
TWI627281B (zh) 2009-09-02 2018-06-21 百靈佳殷格翰家畜藥品公司 降低ｐｃｖ－２組合物殺病毒活性之方法及具有改良免疫原性之ｐｃｖ－２組合物
ES2692809T3 (es) 2011-02-17 2018-12-05 Boehringer Ingelheim Vetmedica Gmbh Nueva cepa del PRRSV europea
CA2827337C (en) 2011-02-17 2019-07-09 Boehringer Ingelheim Vetmedica Gmbh Commercial scale process for production of prrsv
US20140302310A1 (en) * 2011-03-18 2014-10-09 The State of Oregon Acting by and Through the State Board of Higher Education on Behalf of Or... Amorphous multi-component metal/metal oxide nanolaminate metamaterials and devices based thereon
WO2012153160A1 (es) 2011-05-07 2012-11-15 Laboratorio Avi-Mex, S.A. De C.V. Vacuna recombinante contra prrs en vector viral
US9315781B2 (en) 2011-07-29 2016-04-19 Boehringer Ingelheim Vetmedica Gmbh Infectious CDNA clone of european PRRS virus and uses thereof
US9187731B2 (en) * 2011-07-29 2015-11-17 Boehringer Ingelheim Vetmedica Gmbh PRRS virus inducing type I interferon in susceptible cells
US9099230B2 (en) 2012-11-12 2015-08-04 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State Univesity Amorphous metal thin-film non-linear resistor
US9579373B2 (en) 2013-03-15 2017-02-28 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use
CN105829528B (zh) 2013-12-20 2019-10-22 勃林格殷格翰动物保健有限公司 PRRS病毒变体、欧洲PRRS病毒cDNA克隆及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6773908B1 (en) * 1992-10-30 2004-08-10 Iowa State University Research Foundation, Inc. Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
US6592873B1 (en) * 1992-10-30 2003-07-15 Iowa State University Research Foundation, Inc. Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV) and proteins encoded by the polynucleic acids
US20020012670A1 (en) * 2000-01-26 2002-01-31 Knut Elbers Recombinant attenuation of porcine reproductive and respiratory syndrome (PRRSV)
US6841364B2 (en) * 2002-01-22 2005-01-11 Protatek International, Inc. Infectious cDNA clones of porcine reproductive and respiratory syndrome virus and expression vectors thereof

Also Published As

Publication number Publication date
CA2570778A1 (en) 2006-01-05
TW200603825A (en) 2006-02-01
DK1755664T3 (en) 2015-08-24
US7722878B2 (en) 2010-05-25
AR049825A1 (es) 2006-09-06
WO2006002193A2 (en) 2006-01-05
MXPA06014821A (es) 2007-03-26
KR20070028431A (ko) 2007-03-12
RU2007101531A (ru) 2008-07-27
ES2546933T3 (es) 2015-09-30
US20080038293A1 (en) 2008-02-14
WO2006002193A3 (en) 2006-03-02
EP1755664A2 (en) 2007-02-28
BRPI0510930A (pt) 2007-11-20
EP1755664B1 (en) 2015-06-10
AU2005258092A1 (en) 2006-01-05

Similar Documents

Publication Publication Date Title
JP3961222B2 (ja) Ｐｒｒｓｖワクチン
Sola et al. Engineering the transmissible gastroenteritis virus genome as an expression vector inducing lactogenic immunity
EP1755664B1 (en) Prrsv subunit vaccines
JP5793197B2 (ja) 北米型ブタ繁殖・呼吸障害症候群（ｐｒｒｓ）ウイルス及びその使用
KR102270344B1 (ko) Ｐｒｒｓ 바이러스 변이체, 유럽형 ｐｒｒｓ 바이러스 ｃｄｎａ 클론, 및 이들의 용도
EP2275565A2 (en) Nucleic acids encoding TGEV and PRRSV sequences for improved expression of PRRSV sequences
Gao et al. Porcine reproductive and respiratory syndrome virus expressing E2 of classical swine fever virus protects pigs from a lethal challenge of highly-pathogenic PRRSV and CSFV
US20030138916A1 (en) Infectious cDNA clones of porcine reproductive and respiratory syndrome virus and expression vectors thereof
US20100136051A1 (en) N Protein Muants of Porcine Reproductive and Respiratory Syndrome Virus
CN104302316A (zh) 在断奶之前对抗猪繁殖与呼吸综合征(prrs)病毒的有效疫苗接种
US9315781B2 (en) Infectious CDNA clone of european PRRS virus and uses thereof
CN107635579A (zh) 非天然发生的猪生殖和呼吸综合征病毒(prrsv)和使用方法
EP1632247A1 (en) Nucleic acid sequences encoding FMDV proteins capable of associating into a virus-like particle
KR20070064666A (ko) 돼지의 생식 및 호흡 증후군 바이러스 돌연변이
US20250121047A1 (en) Chimeric virus expressing porcine productive and respiratory syndrome virus-derived peptide and vaccine composition comprising same
WO2025012350A1 (en) Vectors expressing attenuated rna virus of the family arteriviridae and uses thereof
CN121718504A (zh) Prrsv疫苗株
HK40004874A (en) Effective vaccination against european strains of porcine reproductive and respiratory syndrome (prrs) virus prior to weaning
CHOULJENKO et al. Elucidation of the Genomic Nucleotide Sequence of Bovine Coronavirus and Analysis of Cryptic Leader
HK1116501A (en) N protein mutants of porcine reproductive and respiratory syndrome virus
HK1153779A (en) Nucleic acids encoding tgev and prrsv sequences for improved expression of prrsv sequences

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080617

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080617

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20100310